Leaflet ROFERON-A 3MUI / 0.5ml solution for injection


Indicated for: viral infections; multiple sclerosis; cancer

Route of administration: injectable

Substance: interferon alfa 2A (antineoplastic agent)

ATC: L03AB04 (Antineoplastic and immunomodulating agents | Immunostimulants | Interferons)

Precautions:
Fertility warning
Fertility warning

This medicine may affect fertility.

Dose adjustment in hepatic impairment
Dose adjustment in hepatic impairment

Dose adjustment may be needed in liver disease.

Cytotoxic / special handling
Cytotoxic / special handling

Handle with special care.

Contraception required
Contraception required

Effective contraception is required during treatment.

Contraindicated during breastfeeding
Contraindicated during breastfeeding

Do not use this medicine while breastfeeding.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hepatotoxicity
Hepatotoxicity

This medicine may affect the liver.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Myelosuppression / agranulocytosis
Myelosuppression / agranulocytosis

This medicine may lower blood cell counts.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Severe skin reactions
Severe skin reactions

Stop taking the medicine and seek urgent medical help if a severe rash occurs.

Interferon alfa-2A is a medication used for the treatment of viral infections, such as chronic hepatitis B and C, and certain types of cancer, such as leukemia. It works by stimulating the immune response and inhibiting viral replication.

The medication is administered as a subcutaneous or intramuscular injection, as directed by a doctor, usually several times a week. It is important for patients to follow the treatment regimen and undergo regular check-ups.

Patients should be aware of potential side effects, such as flu-like symptoms, fatigue, or depression. It is important to inform the doctor of any unusual symptoms.

Common side effects include flu-like symptoms, fatigue, and depression. In rare cases, severe reactions such as liver impairment or hematologic disorders may occur. Patients should be informed of these risks before starting treatment.

General data about ROFERON-A 3MUI / 0.5ml

  • Substance: interferon alfa 2A
  • Date of last drug list: 01-06-2016
  • Commercial code: W51327001
  • Concentration: 3MUI / 0.5ml
  • Pharmaceutical form: solution for injection
  • Quantity: 1
  • Product type: original
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for interferon alfa 2A

  • 18MUI/0.6ml
  • 3MUI/0.5ml
  • 4.5MUI/0.5ml
  • 6MUI/0.5ml
  • 9MUI/0.5ml